{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:03:26Z","timestamp":1778605406676,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,3]]},"DOI":"10.7759\/cureus.27642","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T17:21:18Z","timestamp":1659547278000},"source":"Crossref","is-referenced-by-count":7,"title":["Non-Arteritic Anterior Ischemic Optic Neuropathy Associated With the Use of Phosphodiesterase Type 5 Inhibitors: A Literature Review"],"prefix":"10.7759","author":[{"given":"Mosab","family":"Hor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed  M","family":"Baradeiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hodan","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amad","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v16i2.9088","article-title":"Phosphodiesterase type 5 inhibitors and visual side effects: a narrative review","volume":"16","author":"Barroso F","year":"2021","unstructured":"Barroso F, Ribeiro JC, Miranda EP. Phosphodiesterase type 5 inhibitors and visual side effects: a narrative review. J Ophthalmic Vis Res. 2021, 16:248-59. 10.18502\/jovr.v16i2.9088","journal-title":"J Ophthalmic Vis Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esxm.2018.03.001","article-title":"The association between phosphodiesterase type 5 inhibitor use and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis","volume":"6","author":"Liu B","year":"2018","unstructured":"Liu B, Zhu L, Zhong J, Zeng G, Deng T. The association between phosphodiesterase type 5 inhibitor use and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. Sex Med. 2018, 6:185-92. 10.1016\/j.esxm.2018.03.001","journal-title":"Sex Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S118015","article-title":"Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction","volume":"8","author":"Moschos MM","year":"2016","unstructured":"Moschos MM, Nitoda E. Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction. Drug Des Devel Ther. 2016, 8:3407-13. 10.2147\/DDDT.S118015","journal-title":"Drug Des Devel Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S73059","article-title":"Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements","volume":"8","author":"Karli SZ","year":"2014","unstructured":"Karli SZ, Liao SD, Carey AR, Lam BL, Wester ST. Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements. Clin Ophthalmol. 2014, 8:2171-5. 10.2147\/OPTH.S73059","journal-title":"Clin Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-020-00241-0","article-title":"Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review","volume":"6","author":"da Cruz NF","year":"2020","unstructured":"da Cruz NF, Polizelli MU, Cezar LM, et al.. Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review. Int J Retina Vitreous. 2020, 6:38. 10.1186\/s40942-020-00241-0","journal-title":"Int J Retina Vitreous"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14253","article-title":"Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis","volume":"98","author":"Penedones A","year":"2020","unstructured":"Penedones A, Alves C, Batel Marques F. Risk of nonarteritic ischaemic optic neuropathy with phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis. Acta Ophthalmol. 2020, 98:22-31. 10.1111\/aos.14253","journal-title":"Acta Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000331111","article-title":"Bilateral simultaneous anterior ischemic optic neuropathy associated with sildenafil","volume":"2","author":"Moschos MM","year":"2011","unstructured":"Moschos MM, Margetis I. Bilateral simultaneous anterior ischemic optic neuropathy associated with sildenafil. Case Rep Ophthalmol. 2011, 2:262-5. 10.1159\/000331111","journal-title":"Case Rep Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9030291","article-title":"Visual side effects linked to sildenafil consumption: an update","volume":"9","author":"Aus\u00f3 E","year":"2021","unstructured":"Aus\u00f3 E, G\u00f3mez-Vicente V, Esquiva G. Visual side effects linked to sildenafil consumption: an update. Biomedicines. 2021, 9:291. 10.3390\/biomedicines9030291","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.01.046","article-title":"Male sexual dysfunction: A review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention","volume":"112","author":"Chen L","year":"2019","unstructured":"Chen L, Shi GR, Huang DD, et al.. Male sexual dysfunction: A review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention. Biomed Pharmacother. 2019, 112:108585. 10.1016\/j.biopha.2019.01.046","journal-title":"Biomed Pharmacother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.3","article-title":"Erectile dysfunction","volume":"2","author":"Yafi FA","year":"2016","unstructured":"Yafi FA, Jenkins L, Albersen M, et al.. Erectile dysfunction. Nat Rev Dis Primers. 2016, 2:16003. 10.1038\/nrdp.2016.3","journal-title":"Nat Rev Dis Primers"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.2016.34.2.89","article-title":"Modifying risk factors in the management of erectile dysfunction: a review","volume":"34","author":"DeLay KJ","year":"2016","unstructured":"DeLay KJ, Haney N, Hellstrom WJ. Modifying risk factors in the management of erectile dysfunction: a review. World J Mens Health. 2016, 34:89-100. 10.5534\/wjmh.2016.34.2.89","journal-title":"World J Mens Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57101103","article-title":"The prevalence of erectile dysfunction and its association with cardiovascular risk factors in patients after myocardial infarction","volume":"57","author":"Rink\u016bnien\u0117 E","year":"2021","unstructured":"Rink\u016bnien\u0117 E, Gim\u017eauskait\u0117 S, Badarien\u0117 J, D\u017eenkevi\u010di\u016bt\u0117 V, Kovait\u0117 M, \u010cypien\u0117 A. The prevalence of erectile dysfunction and its association with cardiovascular risk factors in patients after myocardial infarction. Medicina (Kaunas). 2021, 57:1103. 10.3390\/medicina57101103","journal-title":"Medicina (Kaunas)"},{"key":"ref13","article-title":"Erectile dysfunction","volume":"94","author":"Rew KT","year":"2016","unstructured":"Rew KT, Heidelbaugh JJ . Erectile dysfunction. Am Fam Physician. 2016, 94:820-7.","journal-title":"Am Fam Physician"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_106_19","article-title":"Prevalence of and risk factors for erectile dysfunction in young nondiabetic obese men: results from a regional study","volume":"22","author":"Molina-Vega M","year":"2020","unstructured":"Molina-Vega M, Asenjo-Plaza M, Banderas-Donaire MJ, et al.. Prevalence of and risk factors for erectile dysfunction in young nondiabetic obese men: results from a regional study. Asian J Androl. 2020, 22:372-8. 10.4103\/aja.aja_106_19","journal-title":"Asian J Androl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.021","article-title":"Phosphodiesterase-5 inhibitors and survival in men with coronary artery disease","volume":"77","author":"Maas R","year":"2021","unstructured":"Maas R, Rodionov RN. Phosphodiesterase-5 inhibitors and survival in men with coronary artery disease. J Am Coll Cardiol. 2021, 77:1551-3. 10.1016\/j.jacc.2021.02.021","journal-title":"J Am Coll Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.aju.2013.07.009","article-title":"Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: current information and new horizons","volume":"11","author":"Ferguson JE 3rd","year":"2013","unstructured":"Ferguson JE 3rd, Carson CC 3rd. Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: current information and new horizons. Arab J Urol. 2013, 11:222-9. 10.1016\/j.aju.2013.07.009","journal-title":"Arab J Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091327","article-title":"Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy","volume":"9","author":"Wang X","year":"2014","unstructured":"Wang X, Wang X, Liu T, He Q, Wang Y, Zhang X. Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy. PLoS One. 2014, 9:e91327. 10.1371\/journal.pone.0091327","journal-title":"PLoS One"},{"key":"ref18","article-title":"Sildenafil-associated hepatoxicity: a review of the literature","volume":"21","author":"Graziano S","year":"2017","unstructured":"Graziano S, Montana A, Zaami S, Rotolo MC, Minutillo A, Busard\u00f2 FP, Marinelli E. Sildenafil-associated hepatoxicity: a review of the literature. Eur Rev Med Pharmacol Sci. 2017, 21:17-22.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref19","article-title":"PDE5 inhibitors","author":"Dhaliwal A","year":"2022","unstructured":"Dhaliwal A, Gupta M. PDE5 inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref20","article-title":"Phosphodiesterase inhibitors","author":"Padda IS","year":"2022","unstructured":"Padda IS, Tripp J. Phosphodiesterase inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-017-1644-5","article-title":"Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis","volume":"49","author":"Gong B","year":"2017","unstructured":"Gong B, Ma M, Xie W, et al.. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol. 2017, 49:1731-40. 10.1007\/s11255-017-1644-5","journal-title":"Int Urol Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2014.04.001","article-title":"Ocular vascular occlusive disorders: natural history of visual outcome","volume":"41","author":"Hayreh SS","year":"2014","unstructured":"Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Prog Retin Eye Res. 2014, 41:1-25. 10.1016\/j.preteyeres.2014.04.001","journal-title":"Prog Retin Eye Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2006.00904.x","article-title":"Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy","volume":"60","author":"Gorkin L","year":"2006","unstructured":"Gorkin L, Hvidsten K, Sobel RE, Siegel R. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract. 2006, 60:500-3. 10.1111\/j.1368-5031.2006.00904.x","journal-title":"Int J Clin Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2021.07.12","article-title":"Atherogenic indices in non-arteritic ischemic optic neuropathy","volume":"14","author":"Ko\u00e7ak N","year":"2021","unstructured":"Ko\u00e7ak N, Yeter V, Turun\u00e7 M, Bayramba\u015f M, Erayd\u0131n B, G\u00fcng\u00f6r \u0130. Atherogenic indices in non-arteritic ischemic optic neuropathy. Int J Ophthalmol. 2021, 14:1041-6. 10.18240\/ijo.2021.07.12","journal-title":"Int J Ophthalmol"},{"key":"ref25","article-title":"Non-arteritic anterior ischemic optic neuropathy","author":"Raizada K","year":"2021","unstructured":"Raizada K, Margolin E. Non-arteritic anterior ischemic optic neuropathy. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2021."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.618353","article-title":"Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale meta-analysis","volume":"8","author":"Liu B","year":"2021","unstructured":"Liu B, Yu Y, Liu W, Deng T, Xiang D. Risk factors for non-arteritic anterior ischemic optic neuropathy: a large scale meta-analysis. Front Med (Lausanne). 2021, 8:618353. 10.3389\/fmed.2021.618353","journal-title":"Front Med (Lausanne)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19408","article-title":"Bilateral sequential non-arteritic anterior ischemic optic neuropathy (NAION)","volume":"13","author":"Shir Yen W","year":"2021","unstructured":"Shir Yen W, Yathavan S, Ramli MA, Siu Wan F, Che Hamzah J. Bilateral sequential non-arteritic anterior ischemic optic neuropathy (NAION). Cureus. 2021, 13:e19408. 10.7759\/cureus.19408","journal-title":"Cureus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2020.08.018","article-title":"Liquorice-associated bilateral non-arteritic anterior ischaemic optic neuropathy","volume":"36","author":"Oribio-Quinto C","year":"2021","unstructured":"Oribio-Quinto C, Collado-Vincueria I, Pineda-Garrido E, Santos-Bueso E. Liquorice-associated bilateral non-arteritic anterior ischaemic optic neuropathy. Neurologia (Engl Ed). 2021, 36:554-6. 10.1016\/j.nrleng.2020.08.018","journal-title":"Neurologia (Engl Ed)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.928274","article-title":"Analysis of macular microperimetry characteristics in non-arteritic anterior ischemic optic neuropathy","volume":"26","author":"Gong H","year":"2020","unstructured":"Gong H, Wang H, Zhou N. Analysis of macular microperimetry characteristics in non-arteritic anterior ischemic optic neuropathy. Med Sci Monit. 2020, 26:e928274. 10.12659\/MSM.928274","journal-title":"Med Sci Monit"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2020.1785509","article-title":"Very poor visual acuity in non-arteritic anterior ischaemic optic neuropathy","volume":"45","author":"Dattilo M","year":"2021","unstructured":"Dattilo M, Tian T, Peragallo JH, Newman NJ, Biousse V. Very poor visual acuity in non-arteritic anterior ischaemic optic neuropathy. Neuroophthalmology. 2021, 45:23-8. 10.1080\/01658107.2020.1785509","journal-title":"Neuroophthalmology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100823","article-title":"Color vision in anterior ischemic optic neuropathy","volume":"19","author":"Pollock SC","year":"2020","unstructured":"Pollock SC, Hubbe RE. Color vision in anterior ischemic optic neuropathy. Am J Ophthalmol Case Rep. 2020, 19:100823. 10.1016\/j.ajoc.2020.100823","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2013.07.010","article-title":"Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases","volume":"27","author":"Galvez-Ruiz A","year":"2013","unstructured":"Galvez-Ruiz A, Arishi N. Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases. Saudi J Ophthalmol. 2013, 27:241-6. 10.1016\/j.sjopt.2013.07.010","journal-title":"Saudi J Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00041327-200503000-00003\u00a0","article-title":"Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases","volume":"25","author":"Pomeranz HD","year":"2005","unstructured":"Pomeranz HD, Bhavsar AR. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol. 2005, 25:9-13. 10.1097\/00041327-200503000-00003\u00a0","journal-title":"J Neuroophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2005.00374.x","article-title":"Unilateral optic neuropathy associated with sildenafil intake","volume":"83","author":"Gruhn N","year":"2005","unstructured":"Gruhn N, Fledelius HC. Unilateral optic neuropathy associated with sildenafil intake. Acta Ophthalmol Scand. 2005, 83:131-2. 10.1111\/j.1600-0420.2005.00374.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2012.26.3.235","article-title":"Anterior ischemic optic neuropathy associated with udenafil","volume":"26","author":"Kim IG","year":"2012","unstructured":"Kim IG, Kim DY. Anterior ischemic optic neuropathy associated with udenafil. Korean J Ophthalmol. 2012, 26:235-8. 10.3341\/kjo.2012.26.3.235","journal-title":"Korean J Ophthalmol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/747658","article-title":"Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of sildenafil for erectile dysfunction","volume":"2012","author":"Tarantini A","year":"2012","unstructured":"Tarantini A, Faraoni A, Menchini F, Lanzetta P. Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of sildenafil for erectile dysfunction. Case Rep Med. 2012, 2012:747658. 10.1155\/2012\/747658","journal-title":"Case Rep Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0805-8","article-title":"Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy","volume":"246","author":"Hayreh SS","year":"2008","unstructured":"Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008, 246:1029-46. 10.1007\/s00417-008-0805-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105992-non-arteritic-anterior-ischemic-optic-neuropathy-associated-with-the-use-of-phosphodiesterase-type-5-inhibitors-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:49Z","timestamp":1707508009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105992-non-arteritic-anterior-ischemic-optic-neuropathy-associated-with-the-use-of-phosphodiesterase-type-5-inhibitors-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.27642","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}